Radiopharmaceutical firm Immunomedics of Morris Plains, NJ, in June announced the resignation of Robert DeLuccia, the company’s president, CEO, and director. DeLuccia began his tenure at Immunomedics in June 1998, when he took over duties previously
Radiopharmaceutical firm Immunomedics of Morris Plains, NJ, in June announced the resignation of Robert DeLuccia, the companys president, CEO, and director. DeLuccia began his tenure at Immunomedics in June 1998, when he took over duties previously handled by the companys founder, Dr. David Goldenberg (SCAN 6/10/98). Dr. Goldenberg will resume the position of CEO, according to the company.
In other Immunomedics management moves, Philippe Barzin, general manager of Immunomedics Europe, will relocate to the companys U.S. headquarters and assume the post of vice president for global marketing and business development.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.
Could a Newly FDA-Cleared C-Arm Device Bolster Efficiency for Interventional Radiologists?
April 22nd 2024In addition to advanced imaging quality and dose efficiency, the Philips Zenition 30 mobile C-arm device emphasizes personalized user profiles and automated customization to help reduce procedure time.